Caitlin G Howe1, Zhigang Li2, Michael S Zens2, Thomas Palys3, Yu Chen4, Jacqueline Y Channon5, Margaret R Karagas2, Shohreh F Farzan6. 1. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA; caitligh@usc.edu. 2. Departments of Epidemiology and. 3. Center for Molecular Epidemiology, Dartmouth College, Lebanon, NH; and. 4. Department of Population Health, New York University School of Medicine, New York, NY. 5. Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine, and. 6. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Abstract
Background: Arsenic exposure has been associated with an increased risk of cardiovascular disease (CVD). Growing evidence suggests that B vitamins facilitate arsenic metabolism and may protect against arsenic toxicity. However, to our knowledge, few studies have evaluated this in US populations.Objective: Our objective was to examine whether higher B vitamin intake is associated with enhanced arsenic metabolism and lower concentrations of preclinical markers of CVD among New Hampshire adults. Methods: We used weighted quantile sum (WQS) regression to evaluate the collective impact of 6 dietary B vitamins (thiamin, riboflavin, folate, niacin, and vitamins B-6 and B-12) on 1) the proportion of arsenic metabolites in urine and 2) 6 CVD-related markers [including urinary 15-F2t-isoprostane (15-F2t-IsoP)] among 418 participants (26-75 y of age) from the New Hampshire Health Study. Contributions of arsenic metabolites to B vitamin-CVD marker associations were also explored in structural equation models. Results: In WQS models, the weighted sum of B vitamin intakes from food sources was inversely associated with the proportion of monomethyl arsenic species in urine (uMMA) (β: -1.03; 95% CI: -1.91, -0.15; P = 0.02). Thiamin and vitamins B-6 and B-12 contributed the most to this association, whereas riboflavin had a negligible effect. Higher overall B vitamin intake was also inversely associated with 15-F2t-IsoP (β: -0.21; 95% CI: -0.32, -0.11; P < 0.01), with equal contributions from the 6 B vitamins, which was partially explained by differences in the proportion of uMMA (indirect effect β: -0.01; 95% CI: -0.04, -0.00).Conclusions: Among New Hampshire adults, higher intakes of certain B vitamins (particularly thiamin and vitamins B-6 and B-12 from food sources) may reduce the proportion of uMMA, an intermediate of arsenic metabolism that has been associated with an increased risk of CVD. Higher overall B vitamin intake may also reduce urinary 15-F2t-IsoP, a marker of oxidative stress and potential risk factor for CVD, in part by reducing the proportion of uMMA.
Background: Arsenic exposure has been associated with an increased risk of cardiovascular disease (CVD). Growing evidence suggests that B vitamins facilitate arsenic metabolism and may protect against arsenic toxicity. However, to our knowledge, few studies have evaluated this in US populations.Objective: Our objective was to examine whether higher B vitamin intake is associated with enhanced arsenic metabolism and lower concentrations of preclinical markers of CVD among New Hampshire adults. Methods: We used weighted quantile sum (WQS) regression to evaluate the collective impact of 6 dietary B vitamins (thiamin, riboflavin, folate, niacin, and vitamins B-6 and B-12) on 1) the proportion of arsenic metabolites in urine and 2) 6 CVD-related markers [including urinary 15-F2t-isoprostane (15-F2t-IsoP)] among 418 participants (26-75 y of age) from the New Hampshire Health Study. Contributions of arsenic metabolites to B vitamin-CVD marker associations were also explored in structural equation models. Results: In WQS models, the weighted sum of B vitamin intakes from food sources was inversely associated with the proportion of monomethyl arsenic species in urine (uMMA) (β: -1.03; 95% CI: -1.91, -0.15; P = 0.02). Thiamin and vitamins B-6 and B-12 contributed the most to this association, whereas riboflavin had a negligible effect. Higher overall B vitamin intake was also inversely associated with 15-F2t-IsoP (β: -0.21; 95% CI: -0.32, -0.11; P < 0.01), with equal contributions from the 6 B vitamins, which was partially explained by differences in the proportion of uMMA (indirect effect β: -0.01; 95% CI: -0.04, -0.00).Conclusions: Among New Hampshire adults, higher intakes of certain B vitamins (particularly thiamin and vitamins B-6 and B-12 from food sources) may reduce the proportion of uMMA, an intermediate of arsenic metabolism that has been associated with an increased risk of CVD. Higher overall B vitamin intake may also reduce urinary 15-F2t-IsoP, a marker of oxidative stress and potential risk factor for CVD, in part by reducing the proportion of uMMA.
Authors: Margaret R Karagas; Heather H Nelson; Peter Sehr; Tim Waterboer; Therese A Stukel; Angeline Andrew; Adele C Green; Jan Nico Bouwes Bavinck; Ann Perry; Steven Spencer; Judy R Rees; Leila A Mott; Michael Pawlita Journal: J Natl Cancer Inst Date: 2006-03-15 Impact factor: 13.506
Authors: Julia E Heck; Mary V Gamble; Yu Chen; Joseph H Graziano; Vesna Slavkovich; Faruque Parvez; John A Baron; Geoffrey R Howe; Habibul Ahsan Journal: Am J Clin Nutr Date: 2007-05 Impact factor: 7.045
Authors: Margaret Kurzius-Spencer; Jefferey L Burgess; Robin B Harris; Vern Hartz; Jason Roberge; Shuang Huang; Chiu-Hsieh Hsu; M K O'Rourke Journal: J Expo Sci Environ Epidemiol Date: 2013-07-17 Impact factor: 5.563
Authors: Brandilyn A Peters; Megan N Hall; Xinhua Liu; Faruque Parvez; Tiffany R Sanchez; Alexander van Geen; Jacob L Mey; Abu B Siddique; Hasan Shahriar; Mohammad Nasir Uddin; Tariqul Islam; Olgica Balac; Vesna Ilievski; Pam Factor-Litvak; Joseph H Graziano; Mary V Gamble Journal: Environ Health Perspect Date: 2015-05-15 Impact factor: 9.031
Authors: Michelle A Mendez; Carmen González-Horta; Blanca Sánchez-Ramírez; Lourdes Ballinas-Casarrubias; Roberto Hernández Cerón; Damián Viniegra Morales; Francisco A Baeza Terrazas; María C Ishida; Daniela S Gutiérrez-Torres; R Jesse Saunders; Zuzana Drobná; Rebecca C Fry; John B Buse; Dana Loomis; Gonzalo G García-Vargas; Luz M Del Razo; Miroslav Stýblo Journal: Environ Health Perspect Date: 2015-06-12 Impact factor: 9.031
Authors: Soma R Mitra; D N Guha Mazumder; Arindam Basu; Gladys Block; Reina Haque; Sambit Samanta; Nilima Ghosh; Meera M Hira Smith; Ondine S von Ehrenstein; Allan H Smith Journal: Environ Health Perspect Date: 2004-07 Impact factor: 9.031
Authors: Gauri Desai; Marie Vahter; Elena I Queirolo; Fabiana Peregalli; Nelly Mañay; Amy E Millen; Jihnhee Yu; Richard W Browne; Katarzyna Kordas Journal: J Nutr Date: 2020-05-01 Impact factor: 4.798
Authors: Miranda J Spratlen; Maria Grau-Perez; Jason G Umans; Joseph Yracheta; Lyle G Best; Kevin Francesconi; Walter Goessler; Poojitha Balakrishnan; Shelley A Cole; Mary V Gamble; Barbara V Howard; Ana Navas-Acien Journal: Environ Int Date: 2018-10-12 Impact factor: 9.621
Authors: Gauri Desai; Gabriel Barg; Marie Vahter; Elena I Queirolo; Fabiana Peregalli; Nelly Mañay; Amy E Millen; Jihnhee Yu; Richard W Browne; Katarzyna Kordas Journal: Int J Hyg Environ Health Date: 2019-10-03 Impact factor: 5.840
Authors: Leah Zilversmit Pao; Emily W Harville; Jeffrey K Wickliffe; Arti Shankar; Pierre Buekens Journal: Int J Environ Res Public Health Date: 2019-10-01 Impact factor: 3.390
Authors: Shohreh F Farzan; Caitlin G Howe; Thomas A Chavez; Tahlia L Hodes; Jill E Johnston; Rima Habre; Genevieve Dunton; Theresa M Bastain; Carrie V Breton Journal: J Expo Sci Environ Epidemiol Date: 2020-07-27 Impact factor: 5.563